Otezla (apremilast)

pCPA File Number: 20892

Negotiation Status:

Concluded without agreement

Indication(s):

Psoriasis, moderate to severe plaque

Sponsor/Manufacturer:

Celgene Inc.

CDA-AMC Project Number:

SR0400-000

pCPA Engagement Letter Issued:

2017-06-26

Negotiation Process Concluded:

2017-09-08